Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - CORNERSTONE THERAPEUTICS INC | b84113e10vk.htm |
| EX-32.2 - EX-32.2 - CORNERSTONE THERAPEUTICS INC | b84113exv32w2.htm |
| EX-31.2 - EX-31.2 - CORNERSTONE THERAPEUTICS INC | b84113exv31w2.htm |
| EX-21.1 - EX-21.1 - CORNERSTONE THERAPEUTICS INC | b84113exv21w1.htm |
| EX-32.1 - EX-32.1 - CORNERSTONE THERAPEUTICS INC | b84113exv32w1.htm |
| EX-10.45 - EX-10.45 - CORNERSTONE THERAPEUTICS INC | b84113exv10w45.htm |
| EX-31.1 - EX-31.1 - CORNERSTONE THERAPEUTICS INC | b84113exv31w1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 3, 2011, with respect to the consolidated financial
statements and schedule included in the Annual Report of Cornerstone Therapeutics Inc. on Form 10-K
for the year ended December 31, 2010. We hereby consent to the incorporation by reference of said
report in the Registration Statements of Cornerstone Therapeutics Inc. on Forms S-8 (File No.
333-119409, effective September 30, 2004, File No. 333-125892, effective June 17, 2005, File No.
333-131037, effective January 13, 2006, File No. 333-133867, effective May 5, 2006, File No.
333-156293, effective December 19, 2008, File No. 333-161326, effective August 13, 2009 and File
No. 333-168542, effective August 5, 2010).
/s/ GRANT THORNTON LLP
Raleigh, North Carolina
March 3, 2011
March 3, 2011